USE OF BIFIDOBACTERIUM LACTIS BL-99 IN PREVENTION AND/OR AMELIORATION OF GASTRITIS

• Main Authors: XUE, Jiangang, LIU, Wei-Hsien, HUNG, Wei-Lian, LIU, Fudong, HOU, Baochao, ZHANG, Haibin, ZHAO, Wen, YIN, Xiaojing
• Format: Patent
• Language: English; French; German
• Published: 09.10.2024
• Subjects: DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MAKING THEREOF; MEDICAL OR VETERINARY SCIENCE; MILK OR CHEESE SUBSTITUTES; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

The use of Bifidobacterium lactis BL-99 in the prevention and/or amelioration of gastritis. The present invention provides the use of Bifidobacterium lactis in the preparation of a composition for preventing and/or ameliorating gastritis, wherein the Bifidobacterium lactis is Bifidobacterium lactis having the deposit number of CGMCC No. 15650. The Bifidobacterium lactis can prevent and/or ameliorate chronic gastritis, and/or prevent and/or ameliorate gastric mucosal atrophy associated with gastritis.